EUVIMEDEUVIMED entdecken
Crossref

Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety

Naif D. Alenzi, Turki M. Alsagoor, Munif F. Alshammari, Emad S. Ali, Abdullah A. Alshehri, Mathed Alajmi, Kholoud Alrowaili

Therapeutic Innovation & Regulatory Science · 19.11.2026

DOI: 10.1007/s43441-026-01078-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 19.11.2026. Verfasst von Naif D. Alenzi und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alenzi, N. D., Alsagoor, T. M., Alshammari, M. F., Ali, E. S., Alshehri, A. A., Alajmi, M., & Alrowaili, K. (2026). Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-01078-9

Vancouver

Alenzi ND, Alsagoor TM, Alshammari MF, Ali ES, Alshehri AA, Alajmi M, et al. Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety. Therapeutic Innovation & Regulatory Science. 2026. doi:10.1007/s43441-026-01078-9

BibTeX
@article{Alenzi2026,
  author = {Alenzi, Naif D. and Alsagoor, Turki M. and Alshammari, Munif F. and Ali, Emad S. and Alshehri, Abdullah A. and Alajmi, Mathed and Alrowaili, Kholoud},
  title = {Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2026},
  doi = {10.1007/s43441-026-01078-9}
}
Kostenlos starten →